查詢結果分析
來源資料
相關文獻
- 腫瘤藥物敏感性試驗(3)--試驗結果及與臨床結果比較
- 醫療器材臨床評估
- 腫瘤藥物敏感性試驗(1)--腫瘤細胞分離與培養
- 腫瘤藥物敏感性試驗(2)--藥物敏感性試驗的方法學
- 醫院藥師在新藥試驗(Investigational Drug)的臨床評估中所扮演角色的探討
- Recent Advances in Perinatal Asphyxia-Pathogenesis, Clinical Assessment and Potential Treatment
- Clinical Evaluation and Management of Pheochromocytoma
- 修正之侷限--誘發運動治療對中風患者的臨床表現分析
- 知柏八味丸治療第II型糖尿病之臨床評估
- 藥物不良反應之臨床評估
頁籤選單縮合
題名 | 腫瘤藥物敏感性試驗(3)--試驗結果及與臨床結果比較=Tumor Chemosensitivity Assay(3): Clinical Evaluation of in Vitro Chemosensitivity Assay |
---|---|
作者 | 楊佩玉; 胡誕寧; 蔡志宏; 黃明立; 吳永康; 黃馨儀; 陳明豐; | 書刊名 | 秀傳醫學雜誌 |
卷期 | 4:3/4 民92.10 |
頁次 | 頁121-127 |
分類號 | 418.31 |
關鍵詞 | 腫瘤藥物敏感性試驗; 臨床評估; 劑量-效應; MTT assay; Tumor chemosensitivity assay; Clinical evaluation; Dose-effect; |
語文 | 中文(Chinese) |
中文摘要 | 過去五年內,我們對107例各種腫瘤患者手術切除標本作了腫瘤細胞的分離培養。其中71例能建立腫瘤細胞培養。在原代培養融合後將腫瘤細胞脫下,用型態學及免疫組化法進行鑑定。 本文係用microculture tetrazolium test(MTT試驗)測定腫瘤細胞的體外藥物敏感度,共對70例測定了4種抗腫瘤藥物(5FU mitomycin adriamycin and cisplatin)的劑量-效應。體外藥物敏感率在大腸直腸癌為5-Fu, 28.6%; adriamycin, 20.7%; mitomycin, 21.4%; cisplatin, 37.4%; 乳癌為5-Fu, 29.4%; adriamycin, 41.2%; mitomycin 17.6%; cisplatin 35.3%。本組有15例作了臨床化學治療,並將其結果與體外藥敏試驗作了比較。結果有3例為真陽性,11例真陰性,1例假陽性。從體外藥敏試驗陽性者預測化療結果準確率為75%,從體外藥敏試驗陰性者預測化療結果準確率為100%。全組藥敏試驗總準確率為93.0%。本文指示體外藥敏試驗可對各種腫瘤的化療有一定參考意義與應用價值。 |
英文摘要 | During the past five years, tumor cells were isolated and cultured from surgical excised specimens from 107 cases with various solid tumors. Tumor cell cultures were established in 71 cases. Tumor cells were detached front the flask after the confluence of primary culture and identified by morphological and immunocytochemical studied. The microculture tetrazolium test (MTT assay) was used to determine the in vitro tumor chemosenstivity. The close-effect of four anticancer drugs (5FU, mitomycin, adriamycin and cisplatin) were determined in 70 cultures. The in vitro chemosenstivity assay sensitive rate in colorectal cancer was: 5-Fu 28.6%; adriamycin, 20.7%; mitomycin, 21.4% and cisplatin, 37.4%. The sensitive rate in breast cancer was: 5-Fu, 29.4%; adriamycin, 41.2%; mitomycin, l7.6% and cisplatin, 35.3%. Clinical effect of chemotherapy was evaluated in 15 cases and compared with the in vitro chemosenstivity assay. There were 3 true-positive eases, 11 true-negative cases and 1 false-positive case. The predictive accuracy for a positive assay was 75%, and the predictive accuracy for a negative assay was 100%. The overall accuracy of in vitro chemosenstivity assay in our group was 93.0%. The results of the present study indicate that the in vitro chemosenstivity assay might provide useful information for assisting the management of various solid tumors. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。